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Abstract 
Background: Rhabdomyosarcoma (RMS) originates from skeletal muscle precursors that fail to differentiate. Hedge-
hog (Hh) signaling and primary cilia contribute to the pathobiology of RMS.
Results: Here we showed ADP ribosylation factor like GTPase 6 (ARL6) localizes at the base of primary cilium, controls 
ciliogenesis and Hh signaling. The transcription of Arl6 is dynamic during the differentiation of myoblasts, company-
ing with the growth and elimination of primary cilia. Arl6 expression is significantly up regulated in cilia-dependent 
RMS cells and tissues. Knockdown of Arl6 inhibits proliferation and promotes apoptosis of RMS RH30 cells through 
defected ciliogenesis and reduced Hh activity.
Conclusions: Taken together, the functions of Arl6 in ciliogenesis and Hh signaling suggest it as a potential RMS drug 
target.
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Background
Rhabdomyosarcoma (RMS) is the most common soft tis-
sue sarcoma in children, which originates from skeletal 
muscle precursors that fail to differentiate [1]. Current 
therapeutic approaches for RMS include multi-agent 
chemotherapy, radiation therapy and surgical resection, 
which have not resulted in significant improvement in 
outcome for patients with recurrence and/or metasta-
sis [2]. Recent investigations realized that dysregulation 
in RAS pathway [3], insulin-like growth factor [4], p53 
[5], AKT/mTOR [6] and Hedgehog (Hh) signaling [6–8] 
is associated with the pathobiology of RMS, which sug-
gested those signaling pathways as potential RMS drug 
targets.
Abnormal assembly of primary cilia is recently reported 
in RMS [9]. Primary cilium is a microtubule-based cell 
protrusion present in every interphase cell, functions as 
a sensory organelle on the cell surface to detect a wide 
variety of stimuli [10, 11]. Many gene mutations cause 
defective ciliogenesis or ciliary transport, e.g. intraflagel-
lar transport (IFT) genes, small GTPases and Bardet–
Biedl syndrome (BBS) genes encoding proteins that form 
a complex termed the BBSome [12]. The detailed mecha-
nisms are still not very clear. Vertebrate Hh signaling cas-
cade is initiated by the binding of three Hh ligands, Sonic 
Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert 
Hedgehog (Dhh) to the 12-pass transmembrane receptor 
Patched-1 (Ptch1). Hh signaling is absolutely dependent 
on primary cilia, and requires the IFT machinery for the 
transport and processing of its signaling components in 
primary cilia, including transmembrane receptors, Ptch1, 
Smoothened (Smo), and downstream GLI-Kruppel fam-
ily of transcription factors Gli1-3 as well [12].
ADP ribosylation factor like GTPase 6 (Arl6), also 
named as BBS3, is a member of the Ras superfamily 
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of small GTPase, which is mutated in human Bardet–
Biedl syndrome [13, 14]. Arl6 is required for the cili-
ary localization of the BBSome complex [15], which is 
necessary for ciliary membrane biogenesis and sorting 
membrane proteins to cilia [15, 16]. Studies from Cae-
norhabditis elegans showed that Arl6 undergoes IFT 
[14]. Arl6 GTPase activity is required for Wnt signal-
ing in cultured mammalian cells [17]. Recent studies 
from Arl6 knockout mice also showed that loss of Arl6 
affects retrograde transport of Smo inside cilia [18]. 
However, the function of Arl6 in cilia-related RMS is 
still unknown.
Our data points to the role of Arl6 controlling RH30 
RMS cell growth through ciliogenesis and Hedgehog 
signaling. During the in vitro differentiation of an estab-
lished myoblast cell line, C2C12, we saw dynamic Arl6 
expression and accompanying growth or elimination of 
primary cilia. Further more, Arl6 expression is signifi-
cantly up-regulated in cilia-dependent RMS RH30 cells 
and tissues relative to normal skeletal muscles. RH30 
cells with disrupted Arl6 expression show reduced cilio-
genesis and crippled Hh activity, resulting in retarded cell 
growth as well as increased apoptosis.
Methods
Cell culture and plasmids construction
Wild type (WT) and Arl6 knockout mouse embry-
onic fibroblasts (MEFs) were gifts from Dr. Val C. Shef-
field (University of Iowa, Iowa City, IA, USA), and were 
immortalized following NIH3T3 protocol. A mouse 
myoblast cell line C2C12 and human RMS cell lines RD 
and RH30 are from ATCC. RD and RH30 are derived 
from tumors of the embryonal and alveolar origin, 
respectively. MEFs, RD and RH30 cells were maintained 
in DMEM supplemented with 10% fetal bovine serum 
(FBS), 100 U/ml penicillin and 100 mg/ml streptomycin 
at 37 °C with 5% CO2. C2C12 cells were maintained with 
15% FBS. Mouse Arl6 cDNA was obtained from MGC 
cDNA library (Open biosystems), and cloned into pRK5 
vector with a red fluorescent protein (RFP) tag by PCR. 
The T31R and Q73L mutants of Arl6 were created using 
the Quickchange site-directed mutagenesis kit (Agilent 
Technologies).
The constructs expressing Arl6 short hairpin RNA 
(shArl6) (target sequence: GTCGAATTCCAATCTTGTT) 
and scramble control (shCon) were purchased from 
GeneChem (Shanghai, China). Briefly, the short hair-
pin RNAs were cloned into GV248, which has a hU6 
promoter. The knock-down efficiency of shArl6 was 
validated by quantitative real-time polymerase chain 
reaction (Q-PCR). To generate stable cell lines, shArl6 
or shCon plasmids were transfected in RD or RH30 cells 
using Fugene HD according to the manufacturer’s pro-
cedure (Promega, Madison, WI). Transfected cells were 
selected with 5 μg/ml puromycin for 2 weeks, and used 
for following experiments.
RNA isolation and quantitative PCR
Total RNA was isolated from cultured cells using the 
RNAiso reagent (TaKaRa, Shiga, Japan), and reverse 
transcription was carried out using the PrimeScript RT 
reagent Kit (TaKaRa). Standard reverse transcription pol-
ymerase chain reaction (RT-PCR) was carried out with the 
following primers: mouse Gli1 (5′-TCCAGCTTGGATG 
AAGGACCTTGT-3′ and 5′-AGCATATCTGGCACGG 
AGCATGTA-3′) and mouse Hypoxanthine-guanine pho-
sophoribosyltransferase (HPRT) (5′-TATGGACAGGA 
CTGAAAGAC-3′ and 5′-TAATCCAGCAGGTCAGCAA 
A-3′). Q-PCR was carried out using the FastStart SYBR 
Green Master mix (Roche, Germany) on a LightCycler 96 
System (Roche) with primers for mouse Arl6 (5′-CACC 
GTCGAATTCCAATCTTG-3′ and 5′-ATGGCGTCACT 
AG- CACAAATATG-3′), mouse Gli1 (5′-GCTTGGATG 
AAGGACCTTGTG-3′ and 5′-GCTGATCCAGCCTAAG 
GTTCTC-3′), mouse glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) (5′-AGGTCGG- TGTGAACG-
GATTTG-3′ and 5′-GGGGTCGTTGATGGCAACA-3′), 
human Arl6 (5′-GTGTCTCAGTTGCTGTGTTTAG-3′ 
and 5′-AGCCAGTCTACACCTT- CTTG-3′), human Gli1 
(5′-TCCTCTGAGACGCCATGTTC-3′ and 5′-CAGAC 
AGTCCTTCTGTCCCCA-3′), and human GAPDH 
(5′-ATCATCCCTGCCTCTACTGG-3′ and 5′-GTCAGG 
TCCACCACTGACAC-3′). Experiments were repeated 
at least three times, and samples were analyzed in 
triplicate.
Western blot analysis
After transfection or treatment as described, cells were 
lysed in radioimmunoprecipitation assay buffer (RIPA 
buffer) (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% vol/
vol NP-40, 0.25% wt/vol sodium deoxycholate, 0.25% 
wt/vol NaF, 10  mmol/l β-glycerolphosphate, 1  mM 
Na3VO4, 1 mM DTT, and 1× Roche cOmplete Protease 
Inhibitor Cocktail) for 1 h at 4 °C. The lysate was clari-
fied by centrifugation for 1 h at 20,000×g. The protein 
concentration was determined using a bicinchoninic 
acid assay and equal amounts of total protein from 
each of the samples was supplemented with 6× SDS 
loading buffer, heated at 95  °C for 5  min, subjected to 
SDS-PAGE, followed by western blotting with indicated 
antibodies. The source for antibodies are: anti-Arl6 anti-
bodies (Sigma-Aldrich, St. Louis, MO); anti-myogenin 
and anti-β-actin antibodies (Santa Cruz Biotechnology, 
Dallas, TX).
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Immunohistochemical staining
Ptch1+/− mice (Jackson Laboratory, Bar Harbor, ME) 
were outcrossed onto the CD1 background for sponta-
neous RMS development. RMS and normal muscle tis-
sues were dissected from gastrocnemius of hindlimbs of 
Ptch1+/− mice. Immunohistochemistry of tissue sections 
with antibodies to Gli1 (Cell Signaling Technologies, 
Danvers, MA) and Arl6 (Sigma-Aldrich) was performed 
using Polink-2 plus® Polymer HRP Detection System 
(ZSGB-BIO, China). Nuclei were counterstained with 
hematoxylin. Sections were visualized under 40× magni-
fication using Leica DMI 3000B.
Immunofluorescent staining and confocal microscopy
Approximately 5 × 104 cells per well were seeded in Mil-
licell EZ slides and cultured for 24 h. The cells were trans-
fected, allowed to recover for 24–36 h. MEFs were treated 
with 0.5% FBS for 24 h to induce cilia growth. C2C12 or 
RMS cell lines were treated with 2% horse serum (HS) 
for 48 h to induce cilia growth. Cells were fixed with 4% 
paraformaldehyde for 10 min at 4 °C, and standard pro-
cedures for immunostaining were followed. Primary cilia 
were stained with mouse anti-acetylated tubulin (1:2000, 
Sigma-Aldrich) and corresponding Alexa-coupled sec-
ondary antibodies (1:200, Life Technologies). Tissue sec-
tions were immunostained with anti-acetylated tubulin. 
Confocal images were acquired on a Carl Zeiss LSM710 
microscope system using Z-stack module of ZEN2011 
program.
MTT assay
To measure cell growth, RD and RH30 cells stably 
expressing shArl6 or control shRNA were seeded at 3000 
cells per well in 96-well plates. For 5  days, cells were 
incubated with 100  μl MTT (3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyl-tetrazoliumbromide, 5  mg/ml) for 
4 h at 37  °C. Following MTT incubation, 100 μl DMSO 
was added to dissolve the crystals and the absorbance 
at 490 nm was measured using a microplate absorbance 
reader (Tecan, Austria). Each assay was performed in 
triplicates and repeated three times independently.
EdU incorporation
To measure cell proliferation, RD and RH30 cells sta-
bly expressed expressing shArl6 or control shRNA were 
seeded at 2 × 104 cells per well in 24-well plates and cul-
tured for 48 h. Cells were incubated with 10 μM EdU for 
2 h before the end of the culture period. Following cul-
ture, cells were, fixed with 3.7% formaldehyde, and then 
detected with Click-iT EdU Imaging Kit (Life Technolo-
gies, CA) according to the manufacturer’s procedure 
(Life Technologies, CA). The plates were visualized under 
20× magnification using Leica DMI 3000B with Leica 
DFC490 Digital Camera. Quantification of percentage 
of EdU-positive cells was performed using the ImageJ 
program.
Cell cycle and apoptosis assays
Subconfluent RH30 stable cells were synchronized with 
0.5% FBS for 24 h, then rescued with 10% FBS for 12 h 
before cell cycle analysis. To assess cell cycle properties, 
cells were collected and incubated with 100  μg/ml pro-
pidium iodide and 0.5 μg/ml RNase A for 30 min at the 
room temperature before subjecting to FACS analysis. 
To assess apoptosis, stable cells were cultured with 0.2% 
FBS for 72 h to induce apoptosis. The apoptotic cells were 
analyzed using the Annexin V: FITC apoptosis detec-
tion kit according to the manufacturer’s instruction (BD, 
USA).
Generation of Arl6‑knockout RH30 cells
To make CRISPR/Cas9 constructs, a pair of sin-
gle guide RNAs (sgRNAs) targeted human Arl6 were 
designed and cloned into pX330 vector (from Addgene) 
[19]. Arl6 sgRNAs target sequences are 5′-TGC-
CACTATTATCTAGCCCAAGG-3′ and 5′-GACA-
GACTTTCAGTCTTGCTTGG-3′. To generate Arl6 
knockout cells, RH30 cells were co-transfected with 
CRISPR/Cas9 plasmids and the ones encoding puromy-
cin selection marker. 48 h after transfection, transfection-
positive cells were selected using puromycin. After 5 days 
of selection, survived RH30 cells were seeded at 30 cells 
per well in 96-well plates and screened for Arl6 levels by 
western blotting.
Statistical analysis
Statistical analyses were performed in the GraphPad 
Prism 5.0 environment. Comparisons between indicated 
groups were performed using independent-samples t 
test. P values less than 0.05 were considered statistically 
significant. *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
Arl6 controls ciliogenesis and Hh signaling from the basal 
body to the primary cilium
Arl6 is a small GTPase critical for ciliary transport of 
BBSome [15, 20]. To determine the ciliary localization of 
Arl6, we ectopically expressed mouse Arl6 tagged with 
RFP (Arl6-RFP) in MEF cells, then serum-starved those 
MEF cells with 0.5% FBS for 24 h to induce ciliogenesis. 
The Arl6-RFP predominantly distributed in cytoplasm 
but not nucleus. With the anti-acetylated tubulin staining 
of primary cilia, we also found accumulation of Arl6-RFP 
at the base of cilia (Fig. 1a). However we didn’t find local-
ization of Arl6 in primary cilia as it reported before [15]. 
The failed modification of ectopically expressed Arl6 is 
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one possible reason for its failed transport into cilia. To 
access whether the GTP binding is necessary for localiza-
tion of Arl6 at ciliary base, we ectopically expressed Arl6 
mutants T31R and Q73L in MEFs as well. T31R is a dom-
inant-negative mutant appears exclusively bound to GDP, 
while Q73L is a constitutively active mutant appears 
strictly bound to GTP. Under confocal microscope, we 
found that Q73L mutant accumulated at the base of cilia 
as WT did, while T31R didn’t, although they expressed 
at similar levels (Fig. 1a, b). It suggested that GTP-bound 
Arl6 functions at the base of primary cilia.
It was reported that Arl6 functions at or near the ciliary 
gate to modulate mammalian ciliary assembly or disas-
sembly and ciliary signaling, for example Wnt Signaling 
[17]. To understand the function of Arl6 at the base, we 
immortalized Arl6−/− MEFs derived from E13.5 Arl6 
knockout mice [18]. Our immortalized Arl6−/− MEFs 
showed reduced numbers and length of primary cilia 
(Fig. 1c, d), although ciliary staining was normal in tissue 
sections from kidney, eye, and pancreas of Arl6−/− mice 
[18]. Vertebrate Hh signaling absolutely requires IFT [4]. 
To assess the role of Arl6 in Hh signaling, we quantified 
the transcriptional responses of endogenous Gli1 by RT-
PCR and Q-PCR in Arl6−/− MEFs, and found that lack of 
Arl6 led to marked curtailment of Gli1 activation (Fig. 1e, 
f; Additional file 1: Figure S1). Knockdown of Arl6 leads 
to a 42.5% decrease of Hh pathway activation. This result 
is consistent with the disruption of ciliogenesis in Arl6−/− 
MEFs. Taken together, the above results show that Arl6 is 
required for ciliogenesis and vertebrate Hh signaling.
Arl6 is expressed dynamically during muscle 
differentiation
To address the function of Arl6, we first examined the 
expression pattern in adult mouse tissues by Q-PCR. 
High expression of Arl6 was found in brain, kidney and 
lung, which have plenty of ciliated cells (Fig. 2a). In con-
trast, little expression was found in heart, skeletal mus-
cle and colon, which are muscle tissues without cilia 
(Fig. 2a). Arl6 expression pattern in mouse is quite similar 
as that in human according to records from The Human 
Protein Atlas database (http://www.proteinatlas.org/
ENSG00000113966-ARL6/tissue). It suggested that Arl6 
functions in ciliogenesis or ciliary transport in mammals.
Although primary cilia are missing in mature mus-
cle, they grow in myoblasts. Recent study reported that 
assembly and disassembly of primary cilia are controlled 
during the differentiation of myoblasts [9]. To under-
stand whether Arl6 contributes to ciliogenesis during 
muscle differentiation, we induced the differentiation 
of C2C12 myoblasts with 2% HS for 3  days, and ana-
lyzed ciliary formation and Arl6 expression at different 
time points. The increased expression of differentiation 
marker Myogenin over time indicates C2C12 cells dif-
ferentiated well as we expected (Additional file 2: Figure 
S2B). We found that primary cilia were assembled during 
the early stage of myogenic differentiation (0–24 h after 
HS treatment), subsequently disappeared during the later 
period (24–72 h after HS treatment) through immunoflu-
orescent staining of acetylated tubulin (Additional file 2: 
Figure S2A). The numbers and length of cilia reached the 
peak at 24 h time point (Fig. 2b, c). This result is consist-
ent with that of primary mouse myoblasts [9]. Interest-
ingly, the transcription of Arl6 was also dynamically 
regulated during the differentiation of C2C12 cells. The 
mRNA level of Arl6 was also at the peak at 24  h time 
point according to Q-PCR analysis (Fig. 2d). So the regu-
lation of Arl6 expression synchronized with that of cili-
ogenesis. These results suggested that Arl6 participates 
ciliogenesis during muscle differentiation.
Up‑regulation of Arl6 is related to RMS
It is reported that ciliogenesis is deregulated in RMS, 
which is derived from myogenic precursors [9]. We found 
that primary cilia were observed only in RH30 cells but 
not RD cells after 48  h treatment with 2% HS (Fig.  3a), 
which is consistent with the reports from other groups 
[7, 9]. Interestingly, mRNA level of Arl6 was increased 
dramatically in RH30 cells compared with SKM and RD 
cells (Fig.  3b left). Meanwhile our Q-PCR also showed 
dramatic increase of Gli1 in RH30 cells as well (Fig.  3b 
right). It is well known that aberrant Hh activity initi-
ates or promotes RMS tumorigenesis [21, 22]. Previous 
studies have shown that RMS formation in the patients 
with Ptch1 mutation and Ptch1+/− mice as well [23]. So 
we are curious whether Arl6 is involved in Hh-associated 
RMS in vivo. To answer this question, we separated RMS 
tumor tissues and normal gastrocnemius tissues from 
same Ptch1+/− mouse for IHC staining. The IHC results 
showed a robust Arl6 and Gli1 expression in RMS tissues 
(Fig.  3d, f ). In contrast, in the gastrocnemius control, 
Arl6 and Gli1 expression was barely detectable (Fig.  3c, 
e). The typical primary cilia were seen in RMS sections 
but not in normal skeletal muscle control (Fig.  3g, h). 
These in  vitro and in  vivo evidences suggested that up-
regulation of Arl6 caused abnormal assembly of primary 
cilia and aberrant activation of Hh signaling in RMS.
Arl6 promotes RH30 cell growth and inhibits ciliogenesis 
in RH30 cells
Having found the correlation between Arl6 expression, 
ciliogenesis and Hh signaling, we sought to address the 
physiological relevance of Arl6 regulation of ciliogen-
esis in RMS tumorigenesis. For this purpose, we gener-
ated RD and RH30 stable cell lines expressing shArl6 
or shCon, and measured their proliferation. Relative to 
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Fig. 1 Arl6 regulates ciliogenesis and Hedgehog signaling transduction at the base of primary cilium. a Confocal images showing distribution of 
exogenously expressed Arl6-RFP (red) or its T31R, Q73L mutants in MEFs. Arl6-RFP and its Q73L mutant accumulated in basal body of primary cilium 
(green), but T31R did not. b Western blot showing the same expression level of Arl6-RFP and its mutants in MEFs. β-actin was used as a loading 
control. c Representative confocal images of anti-acetylated tubulin (green) showing the lack of primary cilium in stable Arl6−/− MEFs compared to 
WT. Nucleus are stained with DAPI (blue). d Quantitation of percentage (left) and ciliary length (right) of ciliated cells from c. e RT-PCR detection of 
Gli1, Arl6 in WT and Arl6−/− MEFs stimulated with Shh conditional medium. HPRT mRNA was used as an internal control. A representative gel image 
is shown here. The relative intensity of the bands is shown in Additional file 1: Figure S1. f Q-PCR quantification of fold induction of Gli1 mRNA from 
an experiment as in e. Fold induction was calculated using Gli1 mRNA level normalized against that of HPRT for even loading and then against 
the normalized Gli1 mRNA level from WT cells without Shh treatment. The results represent the mean ± standard error of the mean (SEM) of three 
independent experiments *P < 0.05, ***P < 0.001 vs. Arl6+/+ control
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those expressing shCon, RH30 cells expressing shArl6 
grew much slower and had reduced rate of metabolism as 
evident by quantification using MTT (Fig. 4a). Company-
ing with the decrease of Arl6 expression, the mRNA level 
of Gli1 was significantly decreased in RH30 cells express-
ing shArl6 (Fig.  4c, d). However, knockdown of Arl6 
didn’t reduce the rate of metabolism and Gli1 expression 
in RD cells (Fig. 4b, e, f ). The mRNA levels of Hh target 
genes Ptch1, Hhip, and Gli2 were significantly decreased 
in RH30 but not RD cells knockdown of Arl6 (Fig. 4g–l). 
The decreased expression of Dhh and increased Ihh 
was found in RH30 and RD cells knockdown of Arl6 
(Fig. 4m–p). Shh was undetectable. This result suggested 
that knockdown of Arl6 suppress Hh pathway activity 
through retarding the signaling transduction not ligands 
expression in RH30 cells. We then examined the role of 
Arl6 in sustaining the proliferation of RD and RH30 cells. 
Consistent with the decrease of rate of metabolism, the 
proliferation of RH30 cells was blocked by knockdown 
of Arl6 (Fig.  4q, r) according to the EdU incorporation 
results. Taken together, these results indicate that knock-
down of Arl6 inhibits the growth and Hh activity of RH30 
cells.
To understand the mechanisms underlying the growth 
suppression effect of Arl6 knockdown, the cell cycle dis-
tribution of RH30 cells was analyzed. Knockdown of Arl6 
induced G2/M phase arrest in RH30 cells. The fraction 
of RH30 cells in the G2/M phase increased from around 
11.6% in the shCon to around 15.4% in the shArl6 treat-
ment groups (Fig. 5a, b). The G2/M arrest was largely at 
the expense of the G0/G1 phase.
To further characterize the tumor suppression prop-
erties of Arl6 knockdown, we examined the ability of 
RH30 cells to undergo apoptosis when stably expressing 
shArl6. Apoptosis was induced by maintaining the cells 
in DMEM supplemented with 0.2% FBS for 24  h and 
quantified by using Annexin V and propidium iodide 
double staining. Flow cytometry analyses indicated that 
only around 1.5% of RH30 cells expressing shCon became 
Annexin V positive, but this percentage increased to 
11.6% in the cells expressing shArl6 after serum depletion 
(Fig. 5c, d). This result indicated that knockdown of Arl6 
promotes the apoptosis of RH30 cells, and suggested that 
cell cycle arrest at G2/M phase is involved in apoptosis 
induction.
Since knockdown of Arl6 only obstructed the growth 
of RH30 cells but not RD cells, we expected the effect 
of shArl6 is related to the interruption of ciliogenesis in 
RH30 cells. So we stained the primary cilia in those RH30 
stable cells, and found that RH30 cells stably expressing 
shArl6 could not form cilia even after 48  h treatment 
with 2% HS (Fig. 6a). As shown in Fig. 6b, around 26.1% 
RH30 cells stably expressing shCon showed typical struc-
tures of primary cilia, while only 7.5% RH30 cells stably 
expressing shArl6 had primary cilia after the induction 
of ciliogenesis with HS. Those data suggested that knock-
down of Arl6 suppressed RH30 cell proliferation through 
interrupted ciliogenesis.
To identify the role of cilia assembly in RMS cell pro-
liferation, we tried to knockdown IFT88 in RH30 cells 
(Additional file  3: Figure S3A). IFT88 is a well-known 
central component of the IFT complex B, essential for 
cilia assembly. Knockdown of IFT88 blocked cilia assem-
bly, retarded Hh signaling, and suppressed cell prolif-
eration (Additional file  3: Figure S3). The siIFT88 data 
identified that blocking cilia assembly suppresses Hh 
signaling and cell proliferation in RH30 cells.
To further investigate the functions of Arl6 in cili-
ogenesis and cell proliferation of RH30 cells, we used 
the CRISPR/Cas9 genome editing technology to knock-
out Arl6. Western blotting showed that the expression of 
Arl6 was significantly decreased in RH30 cells edited by 
Arl6 CRISPR, indicated Arl6 was knockout in most cells 
of the selected individual clone (Additional file 4: Figure 
S4A). The ciliogenesis and cell proliferation was also sup-
pressed in edited RH30 cells when compared with that in 
Fig. 2 Primary cilia and Arl6 are dynamically regulated during 
myogenic differentiation of C2C12 cells. a Q-PCR quantification 
of Arl6 in mouse tissues. The results represent the mean ± SEM of 
three independent experiments. Quantitation of percentage (b) and 
ciliary length (c) of ciliated C2C12 cells during myogenic differentia-
tion. Cells were incubated in differentiation medium containing 2% 
HS for 3 days. The error bars denote SEM. Representative confocal 
images are shown in Additional file 2: Figure S2. d Q-PCR analysis of 
mRNA level of Arl6 during differentiation. The data represents the 
mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01, 
and ***P < 0.001 vs. 0 h
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untransfected cells (Additional file 4: Figure S4B–D). The 
data again indicated that Arl6 promotes cell growth and 
ciliogenesis in RH30 cells.
Hh signal induces the transcription of Arl6
Until now, we understand that Arl6 is involved in cili-
ogenesis and Hh signaling in myoblast differentiation 
and RMS tumorigenesis. However, the up-regulation 
of Arl6 in RMS tissues from Ptch1+/− mouse is still not 
explained. To answer this question, we incubated wild 
type MEFs with Shh conditioned medium. As shown 
in Fig.  7, the Shh ligand induced Arl6 transcription in 
MEFs, indicating that Arl6 may be the direct or indirect 
target gene of Hh pathway. It suggested a positive feed-
back loop between Hh signal and Arl6.
Discussion
RMS is the most common pediatric soft-tissue sarcoma 
that displays defective myogenic differentiation. Under-
standing the mechanisms in RMS development is impor-
tant to invent innovative treatment strategies. In this 
study, we investigated the role of a small GTPase Arl6 
in regulating RMS cell growth. Our research indicates 
that Arl6 is an oncogene in RMS cells. Arl6 expression 
is significantly up regulated in cilia-dependent human 
RMS cells RH30 and mouse RMS tissues. Knockdown of 
Arl6 obstructs the proliferation and promotes apoptosis 
of RH30 through defected ciliogenesis and reduced Hh 
activity.
Ciliogenesis is required for the differentiation of diverse 
cell types, for example, cardiomyocyte [24], adipocyte 
Fig. 3 Arl6 and Hedgehog pathway is deregulated in ciliated RMS. a Representative images of anti-acetylated tubulin (red) staining in RD and RH30 
cell lines. RMS cells were treated with 2% HS for 48 h before fixation for ciliogenesis. b Q-PCR quantification of Arl6 (left), Gli1 (right) in RD and RH30 
cells, as well as in normal skeletal muscles (SKM). The data represents the mean ± SEM of three independent experiments. **P < 0.01 vs. RD. IHC 
staining of Arl6 (c, d) or Gli1 (e, f) in normal muscle and RMS from Ptch1+/− mouse. g, h Staining of primary cilia (red) and nuclei (blue) in the same 
tissues from c–f
Page 8 of 11Liu et al. Cell Biosci  (2016) 6:61 
[25], myocyte [9, 26], osteocyte [27], and mesenchymal 
stem cells as well [28]. Assembly and disassembly of pri-
mary cilia are dynamical during the myogenic develop-
ment. Primary cilia were assembled during the early stage 
of myogenic differentiation, subsequently disappeared 
during the later period. Interruption of cilia assembly with 
knockdown of IFT genes enhances the cell proliferation of 
myoblasts and abolishes the differentiation [9]. However, 
primary cilia assembly and disassembly are deregulated in 
RMS that originates from poorly differentiated myoblasts. 
Some kinds of RMS cells (A204, RH30, and Rh36) are cili-
ated [9]. We found that interruption of cilia assembly with 
knockdown of Arl6 obstructed cell proliferation and pro-
moted apoptosis in ciliated RH30 cells. It suggests that the 
ciliary signaling transductions regulating cell cycle are dif-
ferent between myoblasts and RMS cells.
Arl6 is a ciliary protein, which accumulates at the base 
of primary cilia in our in vitro cultured MEFs and ciliated 
murine inner medullary collecting duct (IMCD3) cells 
[17], as well as in C. elegans [14]. This localization of Arl6 
suggests its function in ciliogenesis and ciliary trafficking. 
However, recent study in Arl6 knockout mice indicated 
that Arl6 is dispensable in ciliogenesis, since the cilia mor-
phology was completely normal in tissue sections from 
kidney, eye, and pancreas of Arl6−/− mice [18]. There are 
numerous mice studies show that the phenotypic effects of 
single gene knockout are influenced by the genetic back-
ground [29]. It is possible that genetic redundancy masks 
some essential functions of Arl6 in those knockout mice. 
It is also possible that some spontaneous mutations dur-
ing immortalization and in vitro short-term serum starva-
tion potentiate cilia defect in Arl6−/− MEFs. In our study, 
primary cilia numbers were significantly decreased in 
in vitro cultured Arl6−/− MEFs compared with WT cells. 
As a small GTPase, the localization of Arl6 in primary cilia 
depends on the binding of GTP. T31R, a mutant of Arl6 
reported in BBS3 pathology, appears strictly bound to 
GDP, although WT Arl6 is primarily bound to GTP. T31R 
mutant was on longer accumulated in basal body of pri-
mary cilia in our experiment. Interestingly, it was reported 
that expression of T31R leaded to stunted cilia in IMCD3 
cells [30]. This result is similar to the loss of ciliogenesis in 
our MEFs and RH30 cells which lost Arl6. Those findings 
suggest that Arl6 regulates ciliogenesis in some situations.
Fig. 4 Knockdown of Arl6 suppresses cell growth of RH30. MTT assays for RH30 (a) and RD (b) cells stably expressing shArl6 or nonsense control. 
Q-PCR detection of Gli1 mRNA levels in RH30 (c) and RD (e) stable cells. The knockdown efficiency of shArl6 in RH30 (d) and RD (f) cells were 
also detected by Q-PCR. Q-PCR detection of Hh target genes Gli2, Hhip and Ptch1 mRNA levels in RH30 (g, h, i) and RD (j, k, l) stable cells. Q-PCR 
detection of Hh ligands Dhh and Ihh mRNA levels in RH30 (m, n) and RD (o, p) stable cells. q Representative fluorescence images and r percentage 
quantification of EdU incorporation assays of RH30 and RD stable cells. The cells were assayed in 24-well plates. The data was obtained in triplicate. 
Data in a–p and r are presented as mean ± SEM of three independent experiments. The error bars denote SEM. *P < 0.05 and **P < 0.01 vs. shCon
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Arl6 is critical for recruiting the polymerized BBSome 
to lipid vesicles as a coat and for targeting the BBSome 
to cilia but not the assembly of it [15]. Normal assembly 
and ciliary trafficking of BBSome is required for ciliary 
Hh signaling. Loss of BBS7, a subunit of BBSome, results 
in accumulation of Smoothened and Patched1 in cilia 
and decreases Hh response [31]. Loss of Arl6 affects the 
retrograde transport of Smoothened in cilia and leads to 
decreases in ciliary Hh signaling [18]. Our quantitative 
PCR for Gli1 from immortalized Arl6−/− MEFs showed 
a slight increase without Hh and a significant decrease 
when stimulated with Hh compared with WT MEFs. 
The deregulation of Hh pathway activation is due to the 
deregulated transport at ciliary base lack of Arl6. Taken 
together with the function of Arl6 in ciliogenesis, Arl6 
is critical to ciliary Hh signaling. In ciliated RMS cells 
and tissues, the Hh signaling was aberrantly activated 
accompanying with the high Arl6 expression. Aber-
rant activation of Hh signaling leads to oncogenic con-
sequences involving deregulation of cell cycle and cell 
Fig. 5 Knockdown of Arl6 induced cell cycle arrest and apoptosis of 
RH30 cells. a FACS analysis of the cell cycle profile in RH30 cells stably 
expressed shArl6 or nonsense control. 10,000 cells were analyzed in 
each sample. Quantitation of cell cycle distribution of RH30 cells from 
experiment (a) was shown in b. For apoptosis assays (c), the cells 
were maintained in DMEM supplemented with 0.2% FBS and pro-
cessed for apoptosis assay 2 days later by Annexin V/PI double stain-
ing and FACS analysis. d Apoptotic rate was shown as the percentage 
of Annexin V + cells. The data represents the mean ± SEM of three 
independent experiments *P < 0.05, **P < 0.01 vs. shCon
Fig. 6 Arl6 is required for ciliogenesis of RH30 RMS cells. a Represent-
ative confocal images showing primary cilium in RH30 cells stably 
expressing shArl6 or shCon with anti-acetylated tubulin (red) staining. 
RMS cells were treated with 2% HS for 48 h to induce ciliogenesis. 
Quantitation of percentage (b) and ciliary length (c) of ciliated cells 
shown in a. The bars denote SEM. *P < 0.05, ***P < 0.01 vs. shCon
Fig. 7 The transcription of Arl6 is induced by Hh signal. Q-PCR quan-
tification of Arl6 in MEFs treated with Shh-conditioned medium har-
vested from the supernatant of HEK293 cells transiently transfected 
with a Shh-encoding plasmid. The results represent the mean ± SEM 
of three independent experiments. *P < 0.05 vs. control
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proliferation not only in RMS but also in other tumors 
as well [32, 33]. Hence, knockdown of Arl6 could inhibit 
the proliferation and promote of apoptosis of RMS cells 
through blockage of ciliary hedgehog signaling. Our 
study also showed that Hh signal could induce the tran-
scription of Arl6. So there may be a positive feedback 
between Hh signaling and Arl6 to accelerate aberrant 
development of RMS.
Conclusions
In conclusion, our data provides evidence that the small 
GTPase Arl6 contributes to RMS cell growth due to its 
function in ciliogenesis and ciliary Hh signaling. While 
Hh signal induces the transcription of Arl6 to form a 
positive feedback loop to maintain the pathway activa-
tion. The function of Arl6 may be dependent on its bind-
ing of GTP, since of the GTP-bound Arl6 localized at 
the basal body of primary cilia. The data supports that 
targeting Arl6 may be successful in the treatment of cili-
ated RMS. More research is needed to develop the com-
pounds inhibiting the expression or GTP-binding of Arl6 
for tumor therapy.
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